Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Cannabisaktien sollten nun den S&P um 60% outperformen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
31 Leser
Artikel bewerten:
(0)

Cardiac Defibrillators - Emerging Markets 2009-2015

DUBLIN, Ireland, October 24, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/hjlv4j/cardiac) has announced the addition of the "Cardiac Defibrillators - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015" report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )


BRICSS Cardiac Defibrillators market forecasts to reach at US$1.7 billion by 2015 at a high CAGR of 9.5% during the analysis period 2009-2015. China accounts for more than 25% of the global value and India claims almost a closer value of the BRICSS market. In terms of CAGR, India is the fastest growing region while China and South Korea are just behind. Forecasts of BRICSS External Defibrillators market value depict nearly half of Implantable Cardioverter Defibrillator market by 2015. In terms of market value, biphasic technologies used in the sector are expected to double the worth of monophasic technologies 2015.

Publication Overview

The report Cardiac Defibrillators - Emerging Markets (Brazil, Russia, India, China, South Africa and South Korea), 2009-2015' reviews the latest trends in the cardiac defibrillators market with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs), government organizations and many more in preferred locations.

The report primarily focuses on:

- Emerging Market Trends
- Advancements in the Technological Space
- Market Demand Of The Segments (By-Region)
- Key Growth Areas and Market Size
- Region-Wise Demand Factor
- Key Competitors Edge
- Investment Strategies


The report covers the market analysis by product types and by technology. The subdivisions are as:

- By Product
a. Implantable Cardioverter Defibrillators (ICD)
b. External Defibrillating Devices or' Automated External Defibrillator (AED)

- By Technology
a. Biphasic
b. Monophasic



Companies Mentioned

- Abbott Vascular Devices
- Abiomed
- Advansource Biomaterials
- Aga Medical Corporation
- Atrium Medical Corp.
- Ats Medical
- Biophan Technologies
- Biosense Webster
- Boston Scientific Corp.
- Cardiac Science Corp.
- Cardiacassist
- Cardica
- Cardiomems
- Cook Group Incorporated
- Cordis Corporation
- Cryolife
- Idev Technologies
- Medtronic



For more information visit http://www.researchandmarkets.com/research/hjlv4j/cardiac

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Cardiovascular Devices


Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2013 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.